P38 MAP kinase inhibitors
US9024041B2 · kind B2 · utility
27Cited by
4References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 2011 |
| Grant date | May 5, 2015 |
| Priority date | — |
| Expiry date | Apr 8, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a compound of formula (I): wherein: J represents (A): or (B): compositions comprising same, processes for preparing said compounds and use thereof in treatment, particularly in the treatment of inflammatory disease, such as asthma, COPD and 15 rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.